United States Pharmaceuticals

Fortress Biotech Inc (FBIO)

Track

Track

Fortress Biotech Inc. experienced notable insider activity, with the most recent transaction occurring on September 23, 2024. CEO Lindsay A. Rosenwald executed a significant purchase of 763,359 shares. Prior to this, various executives engaged in multiple buying actions throughout mid-2024, reflecting a consistent pattern of accumulation by leadership over the past year.
Ticker: FBIO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fortress Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Purchase
Price
18.52
Quantity 17,107 -22.8%
Value US$4,696,759
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
143.09
Quantity 42,092 -39.4%
Value US$1,599,033
1.3
Jin David Chief Financial Officer Officer
Transaction date
Purchase
Price
312.61
Quantity 33,788 -47.2%
Value US$3,563,978
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
7.39
Quantity 5,000 +4.3%
Value US$36,971
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
7.35
Quantity 5,000 +4.4%
Value US$36,764
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
1.64
Quantity 20,000 +0.7%
Value US$32,724
1.8
Klein Dov Non-Executive Director
Transaction date
Sale
Price
1.89
Quantity 10,000 -15.8%
Value US$18,900
1.8
Klein Dov Director Non-Executive Director
Transaction date
Proposed sale
Price
1.76
Quantity 10,000
Value US$17,600
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
1.76
Quantity 10,000 +0.3%
Value US$17,589
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
1.76
Quantity 10,000 +0.3%
Value US$17,589
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
2.38
Quantity 50,000 +1.8%
Value US$118,770
3.8
WEISS MICHAEL S See Remarks Executive Director
Transaction date
Purchase
Price
1.70
Quantity 147,058 +15.0%
Value US$249,999
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
1.70
Quantity 1,567,515 +152.2%
Value US$2,664,776
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
0.28
Quantity 100,000 +0.7%
Value US$28,330
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
9.34
Quantity 10,000 +9.8%
Value US$93,400
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
11.75
Quantity 10,000 +10.8%
Value US$117,500
3.9
ROSENWALD LINDSAY A MD President, CEO & Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
0.84
Quantity 2,395,209 +18.5%
Value US$2,000,000
2.8
Rowinsky Eric K Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 11,976 +1.3%
Value US$10,000
LOBELL J JAY Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 299,401 +22.4%
Value US$250,000
Lu Lucy Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 11,976 +9.9%
Value US$10,000
1.3
Jin David Chief Financial Officer Officer
Transaction date
Purchase
Price
0.84
Quantity 35,928 +2.6%
Value US$30,000
3.8
WEISS MICHAEL S See Remarks Executive Director Large shareholder
Transaction date
Purchase
Price
0.84
Quantity 1,197,604 +8.8%
Value US$999,999
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Purchase
Price
0.68
Quantity 100,000 +0.9%
Value US$67,960
1.3
Jin David Chief Financial Officer Officer
Transaction date
Planned purchase
Price
0.56
Quantity 5,000 +0.4%
Value US$2,800
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Planned purchase
Price
0.56
Quantity 5,000 +0.0%
Value US$2,800
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Purchase
Price
0.70
Quantity 100,000 +0.9%
Value US$69,500
1.8
Klein Dov Non-Executive Director
Transaction date
Sale
Price
2.45
Quantity 5,000 -0.8%
Value US$12,250
Hunter Robyn Chief Financial Officer Officer
Transaction date
Sale
Price
3.13
Quantity 28,292 -14.7%
Value US$88,554
2.8
Rowinsky Eric K Non-Executive Director
Transaction date
Sale
Price
4.45
Quantity 10,000 -1.4%
Value US$44,500
2.8
Rowinsky Eric K Non-Executive Director
Transaction date
Sale
Price
4.31
Quantity 8,000 -1.1%
Value US$34,480
2.8
Rowinsky Eric K Non-Executive Director
Transaction date
Sale
Price
4.20
Quantity 6,000 -0.8%
Value US$25,200
2.8
Rowinsky Eric K Non-Executive Director
Transaction date
Sale
Price
3.86
Quantity 2,000 -0.3%
Value US$7,720
2.8
Rowinsky Eric K Non-Executive Director
Transaction date
Sale
Price
3.80
Quantity 4,000 -0.5%
Value US$15,200
Lorenz Kevin Non-Executive Director
Transaction date
Purchase
Price
0.00
Quantity 50,000
Value US$0
Hunter Robyn Chief Financial Officer Officer
Transaction date
Sale
Price
4.38
Quantity 28,450 -12.9%
Value US$124,611
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Purchase
Price
18.00
Quantity 52,500 +131.2%
Value US$945,000
Hoenlein Malcolm Non-Executive Director
Transaction date
Purchase
Price
18.00
Quantity 16,667 +inf%
Value US$300,006
Lorenz Kevin
Transaction date
Purchase
Price
0.00
Quantity 50,000
Value US$0
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Planned purchase
Price
2.06
Quantity 1,123 +0.0%
Value US$2,313
3.9
ROSENWALD LINDSAY A MD PRESIDENT, CEO & CHAIRMAN Executive Director Large shareholder
Transaction date
Planned purchase
Price
1.10
Quantity 1,467 +0.0%
Value US$1,614
Hunter Robyn Chief Financial Officer Officer
Transaction date
Planned purchase
Price
1.10
Quantity 2,297 +1.1%
Value US$2,527
Avgerinos George SVP, BIOLOGICS OPERATIONS Officer
Transaction date
Sale
Price
1.05
Quantity 97,325 -27.6%
Value US$102,191
Hunter Robyn Chief Financial Officer Officer
Transaction date
Sale
Price
1.29
Quantity 20,370 -7.8%
Value US$26,277
Avgerinos George SVP, BIOLOGICS OPERATIONS
Transaction date
Sale
Price
3.55
Quantity 12,000 -3.3%
Value US$42,600
Avgerinos George SVP, BIOLOGICS OPERATIONS
Transaction date
Sale
Price
3.57
Quantity 19,000 -5.0%
Value US$67,830
Avgerinos George SVP, BIOLOGICS OPERATIONS
Transaction date
Sale
Price
3.59
Quantity 25,593 -6.3%
Value US$91,879
ROSENWALD LINDSAY A MD PRESIDENT, CEO Executive Director Large shareholder
Transaction date
Purchase
Price
25.00
Quantity 40,000 +inf%
Value US$1,000,000
ROSENWALD LINDSAY A MD President and CEO Executive Director Large shareholder
Transaction date
Planned purchase
Price
2.03
Quantity 731 +0.0%
Value US$1,484
Avgerinos George SVP, Biologics Operations Officer
Transaction date
Sale
Price
2.55
Quantity 33,912 -11.6%
Value US$86,476
Avgerinos George SVP, Biologics Operations Officer
Transaction date
Sale
Price
2.54
Quantity 15,000 -4.9%
Value US$38,100
ROSENWALD LINDSAY A MD President and CEO Executive Director Large shareholder
Transaction date
Planned purchase
Price
2.40
Quantity 613 +0.0%
Value US$1,471
ROSENWALD LINDSAY A MD President and CEO Executive Director Large shareholder
Transaction date
Purchase
Price
1.61
Quantity 150,000 +3.2%
Value US$241,500
Hoenlein Malcolm Non-Executive Director
Transaction date
Purchase
Price
1.61
Quantity 25,000 +83.3%
Value US$40,250
3.8
WEISS MICHAEL S Exec. VC - Strategic Dev. Executive Director Large shareholder
Transaction date
Purchase
Price
1.61
Quantity 1,000,000 +16.8%
Value US$1,610,000
HORGAN KEVIN Former Chief Medical Officer
Transaction date
Sale
Price
1.89
Quantity 47,566 -100.0%
Value US$89,976
HORGAN KEVIN Former Chief Medical Officer
Transaction date
Sale
Price
1.81
Quantity 19,000 -100.0%
Value US$34,382
HORGAN KEVIN Former Chief Medical Officer
Transaction date
Sale
Price
1.85
Quantity 101 -100.0%
Value US$187
LOBELL J JAY Non-Executive Director
Transaction date
Purchase
Price
7.37
Quantity 5,000 +1.5%
Value US$36,850
Lu Lucy Chief Financial Officer Officer
Transaction date
Purchase
Price
7.38
Quantity 5,000 +25.6%
Value US$36,900
Lu Lucy Chief Financial Officer Officer
Transaction date
Purchase
Price
7.90
Quantity 4,545 +30.3%
Value US$35,906
LOBELL J JAY Non-Executive Director
Transaction date
Purchase
Price
7.62
Quantity 10,000 +3.1%
Value US$76,231
Weisman Harlan F Chairman and CEO Executive Director
Transaction date
Purchase
Price
7.59
Quantity 10,000 +50.0%
Value US$75,900
Weisman Harlan F Chairman and CEO Executive Director
Transaction date
Purchase
Price
5.71
Quantity 20,000 +inf%
Value US$114,200
LOBELL J JAY Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 25,000 +8.4%
Value US$125,000
Lu Lucy Chief Financial Officer Officer
Transaction date
Purchase
Price
5.00
Quantity 10,000 +inf%
Value US$50,000
RITTER DALE SVP & Chief Accounting Officer Officer
Transaction date
Purchase
Price
5.00
Quantity 5,000 +100.0%
Value US$25,000
SANDAGE BOBBY W PHD President and CEO Executive Director
Transaction date
Purchase
Price
5.00
Quantity 10,000 +87.0%
Value US$50,000
COOPER GLENN L MD See Remarks Executive Director
Transaction date
Purchase
Price
5.30
Quantity 10,000 +33.3%
Value US$52,968
ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 200,000 +8.1%
Value US$1,000,000
Hehenberger Karin M. See Remarks Officer
Transaction date
Purchase
Price
5.00
Quantity 20,000 +2162.2%
Value US$100,000
Beerman Noah D EVP & COO Officer
Transaction date
Purchase
Price
5.00
Quantity 5,000 +100.0%
Value US$25,000
ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.95
Quantity 2,000 +0.1%
Value US$13,900
ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.66
Quantity 2,000 +0.1%
Value US$11,320
ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.67
Quantity 2,000 +0.1%
Value US$11,340
ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.66
Quantity 2,000 +0.1%
Value US$11,320
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-25 2024-09-23 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
17,107 -22.8%
18.52
US$4,696,759 		17,107 -22.8% 18.52 US$4,696,759
2024-07-15 2024-07-11 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
42,092 -39.4%
143.09
US$1,599,033 		42,092 -39.4% 143.09 US$1,599,033
2024-07-12 2024-07-10 B Purchase
1.3
Jin David

Chief Financial Officer

Officer
33,788 -47.2%
312.61
US$3,563,978 		33,788 -47.2% 312.61 US$3,563,978
2024-07-11 2024-07-09 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
5,000 +4.3%
7.39
US$36,971 		5,000 +4.3% 7.39 US$36,971
2024-07-10 2024-07-08 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
5,000 +4.4%
7.35
US$36,764 		5,000 +4.4% 7.35 US$36,764
2024-07-01 2024-06-28 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
20,000 +0.7%
1.64
US$32,724 		20,000 +0.7% 1.64 US$32,724
2024-05-20 2024-05-20 S Sale
1.8
Klein Dov
Non-Executive Director
10,000 -15.8%
1.89
US$18,900 		10,000 -15.8% 1.89 US$18,900
2024-05-17 2024-05-20 PrS Proposed sale
1.8
Klein Dov

Director

Non-Executive Director
10,000
1.76
US$17,600 		10,000 1.76 US$17,600
2024-05-20 2024-05-16 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +0.3%
1.76
US$17,589 		10,000 +0.3% 1.76 US$17,589
2024-05-20 2024-05-16 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +0.3%
1.76
US$17,589 		10,000 +0.3% 1.76 US$17,589
2024-01-09 2024-01-05 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
50,000 +1.8%
2.38
US$118,770 		50,000 +1.8% 2.38 US$118,770
2023-11-16 2023-11-14 B Purchase
3.8
WEISS MICHAEL S

See Remarks

Executive Director
147,058 +15.0%
1.70
US$249,999 		147,058 +15.0% 1.70 US$249,999
2023-11-16 2023-11-14 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
1,567,515 +152.2%
1.70
US$2,664,776 		1,567,515 +152.2% 1.70 US$2,664,776
2023-09-27 2023-09-26 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
100,000 +0.7%
0.28
US$28,330 		100,000 +0.7% 0.28 US$28,330
2023-08-21 2023-08-18 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +9.8%
9.34
US$93,400 		10,000 +9.8% 9.34 US$93,400
2023-08-21 2023-08-17 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +10.8%
11.75
US$117,500 		10,000 +10.8% 11.75 US$117,500
2023-02-14 2023-02-10 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
2,395,209 +18.5%
0.84
US$2,000,000 		2,395,209 +18.5% 0.84 US$2,000,000
2023-02-14 2023-02-10 B Purchase
2.8
Rowinsky Eric K
Non-Executive Director
11,976 +1.3%
0.84
US$10,000 		11,976 +1.3% 0.84 US$10,000
2023-02-14 2023-02-10 B Purchase
LOBELL J JAY
Non-Executive Director
299,401 +22.4%
0.84
US$250,000 		299,401 +22.4% 0.84 US$250,000
2023-02-14 2023-02-10 B Purchase
Lu Lucy
Non-Executive Director
11,976 +9.9%
0.84
US$10,000 		11,976 +9.9% 0.84 US$10,000
2023-02-14 2023-02-10 B Purchase
1.3
Jin David

Chief Financial Officer

Officer
35,928 +2.6%
0.84
US$30,000 		35,928 +2.6% 0.84 US$30,000
2023-02-14 2023-02-10 B Purchase
3.8
WEISS MICHAEL S

See Remarks

Executive Director Large shareholder
1,197,604 +8.8%
0.84
US$999,999 		1,197,604 +8.8% 0.84 US$999,999
2022-12-05 2022-12-01 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
100,000 +0.9%
0.68
US$67,960 		100,000 +0.9% 0.68 US$67,960
2022-12-02 2022-11-30 PP Planned purchase
1.3
Jin David

Chief Financial Officer

Officer
5,000 +0.4%
0.56
US$2,800 		5,000 +0.4% 0.56 US$2,800
2022-12-02 2022-11-30 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
5,000 +0.0%
0.56
US$2,800 		5,000 +0.0% 0.56 US$2,800
2022-10-24 2022-10-21 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
100,000 +0.9%
0.70
US$69,500 		100,000 +0.9% 0.70 US$69,500
2022-04-29 2021-12-28 S Sale
1.8
Klein Dov
Non-Executive Director
5,000 -0.8%
2.45
US$12,250 		5,000 -0.8% 2.45 US$12,250
2022-04-29 2021-09-21 S Sale
Hunter Robyn

Chief Financial Officer

Officer
28,292 -14.7%
3.13
US$88,554 		28,292 -14.7% 3.13 US$88,554
2021-04-09 2021-03-02 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
10,000 -1.4%
4.45
US$44,500 		10,000 -1.4% 4.45 US$44,500
2021-04-09 2021-02-19 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
8,000 -1.1%
4.31
US$34,480 		8,000 -1.1% 4.31 US$34,480
2021-04-09 2021-02-18 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
6,000 -0.8%
4.20
US$25,200 		6,000 -0.8% 4.20 US$25,200
2021-04-09 2021-02-16 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
2,000 -0.3%
3.86
US$7,720 		2,000 -0.3% 3.86 US$7,720
2021-04-09 2021-02-05 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
4,000 -0.5%
3.80
US$15,200 		4,000 -0.5% 3.80 US$15,200
2021-04-09 2021-01-01 B Purchase
Lorenz Kevin
Non-Executive Director
50,000
0.00
US$0 		50,000 0.00 US$0
2020-09-25 2020-09-22 S Sale
Hunter Robyn

Chief Financial Officer

Officer
28,450 -12.9%
4.38
US$124,611 		28,450 -12.9% 4.38 US$124,611
2020-09-01 2020-08-26 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
52,500 +131.2%
18.00
US$945,000 		52,500 +131.2% 18.00 US$945,000
2020-09-01 2020-08-26 B Purchase
Hoenlein Malcolm
Non-Executive Director
16,667 +inf%
18.00
US$300,006 		16,667 +inf% 18.00 US$300,006
2020-03-13 2020-01-01 B Purchase
Lorenz Kevin
50,000
0.00
US$0 		50,000 0.00 US$0
2020-03-13 2019-12-01 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
1,123 +0.0%
2.06
US$2,313 		1,123 +0.0% 2.06 US$2,313
2020-03-13 2019-06-03 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
1,467 +0.0%
1.10
US$1,614 		1,467 +0.0% 1.10 US$1,614
2019-12-31 2019-06-03 PP Planned purchase
Hunter Robyn

Chief Financial Officer

Officer
2,297 +1.1%
1.10
US$2,527 		2,297 +1.1% 1.10 US$2,527
2018-12-13 2018-12-11 S Sale Avgerinos George

SVP, BIOLOGICS OPERATIONS

Officer
97,325 -27.6%
1.05
US$102,191 		97,325 -27.6% 1.05 US$102,191
2018-11-30 2018-11-23 S Sale Hunter Robyn

Chief Financial Officer

Officer
20,370 -7.8%
1.29
US$26,277 		20,370 -7.8% 1.29 US$26,277
2017-12-18 2017-12-14 S Sale Avgerinos George

SVP, BIOLOGICS OPERATIONS
12,000 -3.3%
3.55
US$42,600 		12,000 -3.3% 3.55 US$42,600
2017-12-14 2017-12-13 S Sale
Avgerinos George

SVP, BIOLOGICS OPERATIONS
19,000 -5.0%
3.57
US$67,830 		19,000 -5.0% 3.57 US$67,830
2017-12-14 2017-12-12 S Sale Avgerinos George

SVP, BIOLOGICS OPERATIONS
25,593 -6.3%
3.59
US$91,879 		25,593 -6.3% 3.59 US$91,879
2017-11-08 2017-11-06 B Purchase ROSENWALD LINDSAY A MD

PRESIDENT, CEO

Executive Director Large shareholder
40,000 +inf%
25.00
US$1,000,000 		40,000 +inf% 25.00 US$1,000,000
2017-01-27 2016-12-01 PP Planned purchase ROSENWALD LINDSAY A MD

President and CEO

Executive Director Large shareholder
731 +0.0%
2.03
US$1,484 		731 +0.0% 2.03 US$1,484
2016-09-19 2016-09-16 S Sale Avgerinos George

SVP, Biologics Operations

Officer
33,912 -11.6%
2.55
US$86,476 		33,912 -11.6% 2.55 US$86,476
2016-09-19 2016-09-15 S Sale Avgerinos George

SVP, Biologics Operations

Officer
15,000 -4.9%
2.54
US$38,100 		15,000 -4.9% 2.54 US$38,100
2016-06-17 2016-06-01 PP Planned purchase ROSENWALD LINDSAY A MD

President and CEO

Executive Director Large shareholder
613 +0.0%
2.40
US$1,471 		613 +0.0% 2.40 US$1,471
2014-11-10 2014-11-06 B Purchase ROSENWALD LINDSAY A MD

President and CEO

Executive Director Large shareholder
150,000 +3.2%
1.61
US$241,500 		150,000 +3.2% 1.61 US$241,500
2014-11-10 2014-11-06 B Purchase
Hoenlein Malcolm
Non-Executive Director
25,000 +83.3%
1.61
US$40,250 		25,000 +83.3% 1.61 US$40,250
2014-11-10 2014-11-06 B Purchase
3.8
WEISS MICHAEL S

Exec. VC - Strategic Dev.

Executive Director Large shareholder
1,000,000 +16.8%
1.61
US$1,610,000 		1,000,000 +16.8% 1.61 US$1,610,000
2014-04-23 2014-04-22 S Sale
HORGAN KEVIN

Former Chief Medical Officer
47,566 -100.0%
1.89
US$89,976 		47,566 -100.0% 1.89 US$89,976
2014-04-22 2014-04-21 S Sale
HORGAN KEVIN

Former Chief Medical Officer
19,000 -100.0%
1.81
US$34,382 		19,000 -100.0% 1.81 US$34,382
2014-04-21 2014-04-17 S Sale
HORGAN KEVIN

Former Chief Medical Officer
101 -100.0%
1.85
US$187 		101 -100.0% 1.85 US$187
2013-08-22 2013-08-21 B Purchase
LOBELL J JAY
Non-Executive Director
5,000 +1.5%
7.37
US$36,850 		5,000 +1.5% 7.37 US$36,850
2013-08-22 2013-08-21 B Purchase
Lu Lucy

Chief Financial Officer

Officer
5,000 +25.6%
7.38
US$36,900 		5,000 +25.6% 7.38 US$36,900
2013-07-18 2013-07-17 B Purchase Lu Lucy

Chief Financial Officer

Officer
4,545 +30.3%
7.90
US$35,906 		4,545 +30.3% 7.90 US$35,906
2013-06-21 2013-06-20 B Purchase
LOBELL J JAY
Non-Executive Director
10,000 +3.1%
7.62
US$76,231 		10,000 +3.1% 7.62 US$76,231
2013-06-21 2013-06-20 B Purchase
Weisman Harlan F

Chairman and CEO

Executive Director
10,000 +50.0%
7.59
US$75,900 		10,000 +50.0% 7.59 US$75,900
2013-01-15 2013-01-14 B Purchase
Weisman Harlan F

Chairman and CEO

Executive Director
20,000 +inf%
5.71
US$114,200 		20,000 +inf% 5.71 US$114,200
2012-06-26 2012-06-22 B Purchase
LOBELL J JAY
Non-Executive Director
25,000 +8.4%
5.00
US$125,000 		25,000 +8.4% 5.00 US$125,000
2012-06-26 2012-06-22 B Purchase
Lu Lucy

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2012-06-26 2012-06-22 B Purchase RITTER DALE

SVP & Chief Accounting Officer

Officer
5,000 +100.0%
5.00
US$25,000 		5,000 +100.0% 5.00 US$25,000
2012-06-26 2012-06-22 B Purchase SANDAGE BOBBY W PHD

President and CEO

Executive Director
10,000 +87.0%
5.00
US$50,000 		10,000 +87.0% 5.00 US$50,000
2012-06-26 2012-06-22 B Purchase COOPER GLENN L MD

See Remarks

Executive Director
10,000 +33.3%
5.30
US$52,968 		10,000 +33.3% 5.30 US$52,968
2012-06-26 2012-06-22 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
200,000 +8.1%
5.00
US$1,000,000 		200,000 +8.1% 5.00 US$1,000,000
2012-06-26 2012-06-22 B Purchase
Hehenberger Karin M.

See Remarks

Officer
20,000 +2162.2%
5.00
US$100,000 		20,000 +2162.2% 5.00 US$100,000
2012-06-26 2012-06-22 B Purchase
Beerman Noah D

EVP & COO

Officer
5,000 +100.0%
5.00
US$25,000 		5,000 +100.0% 5.00 US$25,000
2012-01-23 2012-01-23 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
6.95
US$13,900 		2,000 +0.1% 6.95 US$13,900
2012-01-20 2012-01-20 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
5.66
US$11,320 		2,000 +0.1% 5.66 US$11,320
2012-01-19 2012-01-19 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
5.67
US$11,340 		2,000 +0.1% 5.67 US$11,340
2012-01-18 2012-01-18 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
5.66
US$11,320 		2,000 +0.1% 5.66 US$11,320
Explore more

More insider trading research around Fortress Biotech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America